Scinai Immunotherapeutics Ltd. logo

Scinai Immunotherapeutics Ltd.

SCNI | NASDAQ
Chart Builder DCF Calculator
$1.91
+$0.22 (+13.02%)
At close: Sep 22, 2026, 4:00 PM ET
$1.73
-$0.18 (-9.42%)
After-hours: Sep 22, 2026, 7:59 PM ET

Market Data

Market Cap
$873.63K
Enterprise Value
$1.6M
Beta
2.08
Average Volume
188.97K
Shares Outstanding (Diluted)
57M
Shares Change YoY
35723.87%
Institutional Ownership
N/A
Exchange
NASDAQ
ISIN
US09073Q4029

Price Performance

Price Change 1M
-47.8%
Price Change 3M
490.9%
Price Change 6M
152.2%
Price Change YTD
131.7%
Price Change 1Y
16.6%
Price Change 3Y
-81.5%
Price Change 5Y
-99.3%
1M CAGR (ann.)
-31.0%
1Y CAGR (ann.)
-89.2%
5Y CAGR (ann.)
-76.5%
All-Time CAGR
-50.5%

Valuation

PE Ratio
-0.00
Forward PE
N/A
PEG Ratio
0.00
Forward PEG
0.00
PS Ratio
0.58
Forward PS
N/A
PB Ratio
0.07
P/FCF Ratio
-0.12
P/Adj. FCF Ratio
-0.12
P/OCF Ratio
-13.00
EV/Sales
1.07
EV/EBIT
-0.19
EV/EBITDA
-0.24
EV/FCF
-0.21
Earnings Yield
-3678106.5%
FCF Yield
-862.0%
Adj. FCF Yield
-865.9%

Financial Health

Net Cash
$2.2M
Total Debt
$3.58M
Cash & Short-Term Investments
$2.85M
Total Assets
$17.17M
Current Ratio
1.56
Quick Ratio
1.56
Debt / Equity Ratio
0.31
Debt / EBITDA
-0.54
Debt / FCF
-0.48
OCF / Debt
-2.07
Interest Coverage
-39.09
Altman Z-Score
-11.48
Piotroski F-Score
2

Margins & Profitability

Gross Profit Margin
-252.4%
Operating Profit Margin
-563.9%
EBITDA Margin
-445.7%
Net Profit Margin
-177.0%
FCF Margin
-504.2%
Adj. FCF Margin
-506.5%
SBC / Revenue
2.3%
SBC Impact (per share)
-0.4%

Returns

Return on Assets
-15.4%
Return on Equity
-26.6%
Return on Invested Capital
-55.0%
Return on Capital Employed
-56.4%
Return on Tangible Assets
-15.4%

Historical Growth (CAGR)

Revenue CAGR 3Y
58.1%
Revenue CAGR 5Y
69.4%
Revenue CAGR 10Y
47.1%
EPS CAGR 3Y
74.0%
EPS CAGR 5Y
78.8%
EPS CAGR 10Y
30.5%
FCF CAGR 3Y
-4.5%
FCF CAGR 5Y
8.3%
FCF CAGR 10Y
8.2%

Analyst Forecasts

Analyst Rating
Hold
Analyst Count
0
EPS Growth Next 3Y
N/A
Revenue Growth Next 3Y
N/A
Earnings Date
Dec 1, 2026
EPS Estimate (next Q)
-$8.50
EPS Growth Est (next Q)
-76.2%
Revenue Est (next Q)
$494.55K
Revenue Growth Est (next Q)
78.3%

Cash Flow

Operating Cash Flow
$-7.4M
Free Cash Flow
$-7.53M
Adj. Free Cash Flow
$-7.57M
FCF Per Share
-$0.13
OCF Per Share
-$0.13
OCF/S Ratio
-495.7%

Income Statement

Revenue
$1.49M
Gross Profit
$-3.77M
Operating Income
$-8.42M
EBITDA
$-6.66M
Net Income
$-2.64M
EPS (Diluted)
-$62,160
Revenue / Employee
$33.19K
Profit / Employee
$-58.74K
Employees
45

© 2026 bestshares.com. All rights reserved.